22.418 articles found

[Clozapine for the treatment of psychosis in 3 elderly patients with Parkinson's disease].

Diraoui S, van Melick EJ, Jansen PA.

Ned Tijdschr Geneeskd · 2004-11-01

PMID: 15615268

[Comment on guidelines for treatment of Parkinson's disease].

Kondo T.

Rinsho Shinkeigaku · 2004-11-01

PMID: 15651305

[Future of gene therapy for Parkinson's disease].

Mochizuki H.

Rinsho Shinkeigaku · 2004-11-01

PMID: 15651340

[Cell therapy in Parkinson's disease].

Shingo T.

Rinsho Shinkeigaku · 2004-11-01

PMID: 15651341

The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease.

Nagayama H, Hamamoto M, Ueda M, Nito C, Yamaguchi H, Katayama Y.

Clin Neuropharmacol · 2004-11-01

DOI: 10.1097/01.wnf.0000150865.21759.bcPMID: 15613930

Efficacy and safety of piribedil in early combination with L-dopa in the treatment of Parkinson's disease: a 6-month open study.

Suwantamee J, Nidhinandana S, Srisuwananukorn S, Laptikultham S, Pisarnpong A, Chankrachang S, Bundhukul A.

J Med Assoc Thai · 2004-11-01

PMID: 15825702

An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off.

Koller W, Guarnieri M, Hubble J, Rabinowicz AL, Silver D.

J Neural Transm (Vienna) · 2004-10-22

DOI: 10.1007/s00702-004-0184-1PMID: 15503197

Spirofuropyridine aryl ligands for nicotinic acetylcholine receptors and their use in therapy

PHILLIPS EIFION.

· 2004-10-21

IN VIVO GENE THERAPY OF PARKINSON'S DISEASE

TORNOE Jens, ROSENBLAD Carl, WAHLBERG Lars.

· 2004-10-20

Drug targets for the treatment of neurodegenerative disorders

MUCHOWSKI PAUL J, SANCENON GALARZA VICENTE E.

· 2004-10-20

Drug targets for the treatment of neurodegenerative disorders

MUCHOWSKI PAUL J, GIORGINI FLAVIANO.

· 2004-10-20

Drug targets for the treatment of neurodegenerative disorders

MUCHOWSKI PAUL J, SANCENON GALARZA VICENTE E.

· 2004-10-20